Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-24-010322
Filing Date
2024-05-15
Accepted
2024-05-15 16:16:24
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm   iXBRL 10-Q 961072
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 5281
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 5204
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 3031
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3164
  Complete submission text file 0001062993-24-010322.txt   5851986

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igxt-20240331.xsd EX-101.SCH 86059
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igxt-20240331_cal.xml EX-101.CAL 36566
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igxt-20240331_def.xml EX-101.DEF 146163
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igxt-20240331_lab.xml EX-101.LAB 903500
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igxt-20240331_pre.xml EX-101.PRE 279517
81 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 744728
Mailing Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2
Business Address 6420 ABRAMS SAINT LAURENT A8 H4S 1Y2 514-331-7440
IntelGenx Technologies Corp. (Filer) CIK: 0001098880 (see all company filings)

EIN.: 870638336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31187 | Film No.: 24951028
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)